Chronic And Degenerative Neurologic Disorders - USMLE Step 2

1. Which of the following is the most appropriate intervention to address this patient's nutritional and hydration needs and reduce the risk of aspiration?
   Answer: Placement of a percutaneous endoscopic gastrostomy (PEG) tube This patient is exhibiting signs of severe bulbar dysfunction (dysphagia and dysarthria), a common feature of ALS, leading to weight loss and risk of aspiration pneumonia. While dietary modifications like pureed diet are a temporary measure, they often become insufficient and unsafe as dysphagia progresses. Placement of a percutaneous endoscopic gastrostomy (PEG) tube is the standard of care to provide long-term nutritional support, maintain hydration, and reduce the risk of aspiration in patients with ALS and significant dysphagia. It is best placed before respiratory function declines significantly. TPN is invasive and has more complications. Anticholinergics can help with sialorrhea but do not solve the swallowing problem.
2. Which of the following is the most appropriate initial pharmacologic treatment for this patient's cognitive symptoms?
   Answer: Donepezil This patient presents with a classic insidious onset and progressive course of cognitive decline, particularly affecting memory, consistent with Alzheimer's disease (AD). The MRI findings of medial temporal lobe atrophy further support this diagnosis. Donepezil, an acetylcholinesterase inhibitor, is a first-line medication for mild to moderate AD and is the most appropriate initial treatment to manage cognitive symptoms.
3. The sleep-related symptom described in this patient is most strongly associated with which of the following underlying pathologies?
   Answer: Alpha-synuclein deposition The patient's clinical picture, including dementia, parkinsonism (rigidity, slow gait), and REM sleep behavior disorder (acting out dreams), is highly suggestive of a synucleinopathy, most likely Dementia with Lewy Bodies (DLB) or Parkinson's disease dementia. REM sleep behavior disorder is caused by the loss of normal muscle atonia during REM sleep and is very strongly associated with the deposition of alpha-synuclein in the brainstem. Beta-amyloid plaques and tau tangles are the hallmarks of Alzheimer's disease. TDP-43 is associated with frontotemporal dementia and ALS.
4. Pending the MRI results, which of the following is the most appropriate next step in management for her current symptoms?
   Answer: High-dose intravenous corticosteroids This patient's presentation of painful monocular vision loss with an afferent pupillary defect is classic for optic neuritis, a common presenting symptom of multiple sclerosis (MS). Her previous episode of neurologic symptoms suggests dissemination in time. An acute MS exacerbation causing significant functional disability (in this case, vision loss) is treated with high-dose intravenous corticosteroids (e.g., methylprednisolone) to shorten the duration of the relapse. Oral prednisone is less effective and may increase the risk of recurrent optic neuritis. Interferon beta-1a is a disease-modifying therapy used for long-term management, not acute flares. Plasma exchange is reserved for severe, steroid-refractory relapses.
5. Which of the following interventions is most critical to monitor for and implement as his disease progresses to manage respiratory complications?
   Answer: Noninvasive positive pressure ventilation (NPPV) Respiratory failure is the most common cause of death in ALS due to progressive weakness of the diaphragm and other respiratory muscles. Noninvasive positive pressure ventilation (NPPV), typically initiated at night when FVC drops below 50% or when symptoms of nocturnal hypoventilation develop, is the standard of care. NPPV has been shown to improve quality of life and prolong survival. Prophylactic tracheostomy is an invasive option considered later. Incentive spirometry is not effective for neuromuscular weakness. Oxygen therapy is not indicated unless hypoxemia is present, and it can worsen hypercapnia from hypoventilation.
6. What is the most appropriate response by the physician?
   Answer: Ask the daughter about her mother's values and what she would have wanted in this situation. When a patient lacks decision-making capacity and has no advance directive, the healthcare proxy should make decisions based on the principle of substituted judgment—what the patient would have wanted for herself. The physician's role is to guide the proxy in this process. Instead of immediately imposing a recommendation or blindly following the initial emotional request, the most appropriate step is to explore the patient's values, beliefs, and previously expressed wishes with the daughter. This patient-centered approach helps the proxy make a decision that truly honors the patient, rather than one based on guilt or misunderstanding.
7. This patient's clinical course is best described as which of the following?
   Answer: Secondary progressive MS Secondary progressive multiple sclerosis (SPMS) is characterized by a gradual worsening of neurologic disability that is independent of relapses, following an initial relapsing-remitting course. This patient had a history of MS (implying a prior relapsing course) and now has steady progression of disability for 2 years without acute attacks. This transition from relapsing-remitting to progressive disease defines SPMS. Primary progressive MS (PPMS) involves progression from disease onset, without an initial relapsing phase. Clinically isolated syndrome is the first clinical episode suggestive of MS.
8. Which of the following is the most likely diagnosis?
   Answer: Amyotrophic lateral sclerosis This patient's clinical presentation demonstrates a combination of both upper motor neuron (UMN) signs (hyperreflexia, Babinski sign) and lower motor neuron (LMN) signs (asymmetric weakness, atrophy, fasciculations). This constellation of findings in a progressive, painless pattern is classic for amyotrophic lateral sclerosis (ALS). Cervical myelopathy can cause mixed UMN/LMN signs but typically involves the neck and may have sensory deficits. Guillain-Barré syndrome is an acute, ascending paralysis, often with areflexia. Myasthenia gravis presents with fluctuating, fatigable weakness, typically affecting ocular and bulbar muscles first, and does not cause UMN signs.
9. Which of the following is the most appropriate next step to reduce the risk of future relapses and disability progression?
   Answer: Begin a disease-modifying therapy Following a diagnosis of relapsing-remitting multiple sclerosis (RRMS), the standard of care is to initiate a long-term disease-modifying therapy (DMT). These medications (e.g., interferons, glatiramer acetate, natalizumab, ocrelizumab) are proven to reduce the frequency of relapses, delay the accumulation of disability, and decrease the development of new MRI lesions. Steroids are used for acute relapses only, not for long-term prevention. IVIG is not a standard DMT for MS. Observation alone is inappropriate as it allows for irreversible neurologic damage to occur.
10. This patient's presentation is most consistent with which of the following neurodegenerative syndromes?
    Answer: Nonfluent/agrammatic variant primary progressive aphasia This patient has an isolated, progressive language disorder (primary progressive aphasia, PPA). His symptoms of effortful, halting speech with sound errors (phonemic paraphasias) and incorrect grammar (agrammatism), in the setting of preserved comprehension and memory, are the hallmark features of the nonfluent/agrammatic variant of PPA. This is a form of frontotemporal lobar degeneration. Logopenic PPA is characterized by word-finding difficulty and impaired repetition (often associated with Alzheimer's pathology). Semantic variant PPA involves loss of word meaning.
11. Which of the following is the most likely diagnosis?
    Answer: Dementia with Lewy bodies This patient's presentation includes the core features of dementia with Lewy bodies (DLB): fluctuating cognition, visual hallucinations, and parkinsonism. Furthermore, his severe adverse reaction to haloperidol, a typical antipsychotic, demonstrates the classic neuroleptic sensitivity seen in DLB. While Alzheimer's disease can have psychosis, the combination of all these features, especially the fluctuating cognition and profound antipsychotic sensitivity, makes DLB the most likely diagnosis.
12. The MRI is most likely to show a lesion consistent with which of the following conditions?
    Answer: Transverse myelitis This patient's presentation of subacute, bilateral motor and sensory deficits below a specific spinal cord level (T10 dermatome, at the umbilicus), along with upper motor neuron signs (hyperreflexia, Babinski) and bladder dysfunction, is classic for transverse myelitis. This is a common manifestation of multiple sclerosis. MRI of the spine would show a T2-hyperintense, often contrast-enhancing lesion within the spinal cord. An epidural abscess would typically present with fever and severe back pain. An anterior spinal artery infarct spares the dorsal columns (vibration/proprioception). Vitamin B12 deficiency has a more indolent onset.
13. Which of the following is the most appropriate next step in management?
    Answer: Attempt non-pharmacologic behavioral interventions For behavioral and psychological symptoms of dementia (BPSD), non-pharmacologic interventions are first-line, especially when the patient is not an immediate danger. These strategies involve identifying and modifying triggers (e.g., pain, hunger, boredom), establishing routines, providing a calm environment, and using techniques like redirection and reassurance. Antipsychotics carry a black box warning for increased mortality in elderly patients with dementia and should be reserved for severe symptoms that have not responded to non-pharmacologic approaches and pose a risk of harm. Benzodiazepines can worsen confusion and increase fall risk. Increasing donepezil is for cognitive symptoms, not primarily for agitation.
14. The absence of oligoclonal bands and the presence of a longitudinally extensive spinal cord lesion makes which diagnosis more likely than classic multiple sclerosis?
    Answer: Neuromyelitis optica spectrum disorder This patient presents with severe, longitudinally extensive transverse myelitis (a lesion spanning three or more vertebral segments). While transverse myelitis can occur in multiple sclerosis (MS), the lesions are typically shorter. The combination of a longitudinally extensive lesion, a normal brain MRI, and negative CSF oligoclonal bands is highly suggestive of Neuromyelitis Optica Spectrum Disorder (NMOSD), an autoimmune condition often associated with antibodies against aquaporin-4. Distinguishing NMOSD from MS is critical as treatments differ significantly.
15. Which of the following medications has been shown to modestly prolong survival in patients with this condition?
    Answer: Riluzole Riluzole, a glutamate inhibitor, is the first medication approved for amyotrophic lateral sclerosis (ALS) and has been shown in clinical trials to provide a modest survival benefit, typically extending survival by 2-3 months. It is considered a standard of care for patients with ALS. Edaravone is another approved medication that may slow functional decline in a subset of patients, but riluzole is the classic agent with proven survival benefit. Corticosteroids like prednisone and IVIG are not effective in treating ALS.
16. Which of the following is the most appropriate first-line medication for this patient's condition?
    Answer: Carbamazepine The patient's symptoms are characteristic of trigeminal neuralgia, which is a common and often debilitating symptom in patients with multiple sclerosis due to a demyelinating plaque in the trigeminal nerve root entry zone. The first-line treatment for trigeminal neuralgia is carbamazepine, an anticonvulsant that stabilizes neuronal membranes. Oxcarbazepine is also a first-line option. Amitriptyline is a second-line agent. Sumatriptan is for migraine, and propranolol is for migraine prophylaxis or tremor.
17. This patient's difficulty with navigation and dressing suggests impairment in which of the following cognitive domains?
    Answer: Visuospatial function The patient's symptoms of getting lost in familiar places, apraxia (difficulty with motor planning for tasks like dressing), and inability to copy diagrams or draw a clock are classic manifestations of impaired visuospatial function. While Alzheimer's disease (the likely diagnosis) affects multiple domains, these specific symptoms point to significant parietal lobe dysfunction, which is responsible for visuospatial processing. Executive dysfunction would manifest as problems with planning and problem-solving. Language impairment would involve aphasia. Attention deficits would present as distractibility.
18. In addition to lifestyle modifications, which of the following is the most important component of this patient's long-term management?
    Answer: Aggressive control of vascular risk factors This patient's presentation of a stepwise cognitive decline in the setting of multiple vascular risk factors and focal neurologic findings, confirmed by MRI evidence of multiple infarcts, is characteristic of vascular dementia. The primary goal of management is to prevent further strokes and cognitive decline. This is best achieved through aggressive control of vascular risk factors, including hypertension, diabetes, and hyperlipidemia, along with antiplatelet therapy. While cholinesterase inhibitors are sometimes used off-label, their efficacy is limited, and risk factor control is paramount. Levodopa is for Parkinson's disease, and deep brain stimulation is not indicated.
19. Which of the following is the most appropriate initial medication to manage this patient's primary complaint?
    Answer: Baclofen The patient's symptoms of leg stiffness, increased tone, and painful spasms are characteristic of spasticity, a common and disabling symptom in multiple sclerosis resulting from upper motor neuron damage. Baclofen, a GABA-B agonist, is a first-line pharmacologic treatment for MS-related spasticity. Tizanidine is another first-line option. Gabapentin is primarily used for neuropathic pain. Amantadine and modafinil are used to treat MS-related fatigue.

Start this quiz